Last reviewed · How we verify

NCT03732092

The Effects of Olfactory Stimulation on Diagnosis and Prognosis of DOC Patients

Completed Last updated 29 December 2020
What this trial tests

trial testing Coma Recovery Scale-Revised in Minimally Conscious State in 20 participants. Completed in 15 December 2019.

Timeline
15 March 2018
Primary endpoint
15 November 2018
15 December 2019

Quick facts

Lead sponsorJing Wang
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date15 March 2018
Primary completion15 November 2018
Estimated completion15 December 2019
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Jing Wang

Who can join

Adults 18 to 65, any sex, with Minimally Conscious State or Vegetative State. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Analyze the behavioral response of patients with disorders of consciousness through olfactory stimulation, compare the response of olfactory stimulation in patients with different consciousness, and analyze the impact of olfactory stimulation on diagnosis; After the first, third, and sixth months of initial enrollment, the recovery of prognosis was tracked by the Coma Recovery Scale-Revision (CRS-R).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Olfactory Stimulation and the Diagnosis of Patients With Disorders of Consciousness: A Double-Blind, Randomized Clinical Trial.
    Wang J, Zhang S, Liu W, Zhang Y, et al · · 2022 · cited 4× · PMID 35250440 · DOI 10.3389/fnins.2022.712891

Verify or expand the search:

Other trials of Coma Recovery Scale-Revised

Trials testing the same drug.

Other recruiting trials for Minimally Conscious State

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03732092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing